New injection aims to shield liver during cancer surgery
NCT ID NCT07150624
Summary
This study is testing whether a specific injection can help protect the liver from damage during and after surgery to remove part of the liver for cancer. Researchers will compare two groups: one receives the liver-protecting injection before surgery and a combination of injections after, while the other receives only a standard injection after surgery. The goal is to see if the new approach helps patients' liver function recover faster and more safely after the operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.